Floatz logo

Disodium 4-((Tert-Butylimino)Methyl)Benzene-1,3-Disulfonate N-Oxide

Astrocytic Tumor

Oblato, Inc.Small moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Astrocytic Tumor cohort.

Asset / SponsorPhaseRating
Carboplatin
Oliver Jonas
Phase 2BB
Irinotecan
Julie Krystal
Phase 2BB
Trametinib
Novartis Pharmaceuticals
Phase 4BB
Dabrafenib
Novartis Pharmaceuticals
Phase 4BB
(+)-Vincristine
Novartis Pharmaceuticals
Phase 2BB

View all 39 →

Same molecule, other indications

Disodium 4-((Tert-Butylimino)Methyl)Benzene-1,3-Disulfonate N-Oxide is also rated in:

malignant gliomaActive
BB
Indicative · Phase 2
64 / 100
View asset →
brain glioblastomaDormant
B
Indicative · Phase 2
57 / 100
View asset →
glioblastomaActive
CC
Indicative · Phase 1/2
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →